Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| Research & Development Solutions | 7,556.0 | 5,760.0 | 5,788.0 | 5,465.0 | 5,105.0 | | 3,159.0 | 3,050.0 |
| Technology & Analytics Solutions | 5,534.0 | 4,858.0 | 4,486.0 | 4,137.0 | 3,682.0 | | | |
| Contract Sales & Medical Solutions | 784.0 | 741.0 | 814.0 | 810.0 | 915.0 | | | |
| Commercial Solutions | | | | | | | 323.0 | 230.0 |
| Integrated Engagement Services | | | | | | | 844.0 | 885.0 |
| IMS Health Holdings, Inc. | | | | | | | 7,180.0 | |
| |
| EBITDA |
| |
| EBIT |
| |
| Mix |
| Research & Development Solutions | 54.5% | 50.7% | 52.2% | 52.5% | 52.6% | | 55.1% | 55.9% |
| Technology & Analytics Solutions | 39.9% | 42.8% | 40.5% | 39.7% | 38.0% | | | |
| Contract Sales & Medical Solutions | 5.7% | 6.5% | 7.3% | 7.8% | 9.4% | | | |
| Commercial Solutions | | | | | | | 5.6% | 4.2% |
| Integrated Engagement Services | | | | | | | 14.7% | 16.2% |
| IMS Health Holdings, Inc. | | | | | | | 125.2% | |
| |
| Growth |
| Research & Development Solutions | 31.2% | -0.5% | 5.9% | 7.1% | | | 3.6% | |
| Technology & Analytics Solutions | 13.9% | 8.3% | 8.4% | 12.4% | | | | |
| Contract Sales & Medical Solutions | 5.8% | -9.0% | 0.5% | -11.5% | | | | |
| Commercial Solutions | | | | | | | 40.4% | |
| Integrated Engagement Services | | | | | | | -4.6% | |
|